Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Yongjun Cha"'
Autor:
Miso Kim, Hyo Sup Shim, Sheehyun Kim, In Hee Lee, Jihun Kim, Shinkyo Yoon, Hyung-Don Kim, Inkeun Park, Jae Ho Jeong, Changhoon Yoo, Jaekyung Cheon, In-Ho Kim, Jieun Lee, Sook Hee Hong, Sehhoon Park, Hyun Ae Jung, Jin Won Kim, Han Jo Kim, Yongjun Cha, Sun Min Lim, Han Sang Kim, Choong-Kun Lee, Jee Hung Kim, Sang Hoon Chun, Jina Yun, So Yeon Park, Hye Seung Lee, Yong Mee Cho, Soo Jeong Nam, Kiyong Na, Sun Och Yoon, Ahwon Lee, Kee-Taek Jang, Hongseok Yun, Sungyoung Lee, Jee Hyun Kim, Wan-Seop Kim
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 58, Iss 4, Pp 147-164 (2024)
In recent years, next-generation sequencing (NGS)–based genetic testing has become crucial in cancer care. While its primary objective is to identify actionable genetic alterations to guide treatment decisions, its scope has broadened to encompass
Externí odkaz:
https://doaj.org/article/44ffb81b584c45b583bff31f456ec2e9
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundSystemic treatments, namely, either monotherapy or combination therapy, are commonly administered to patients with advanced or metastatic colorectal cancer (CRC). This study aimed to provide the complete efficacy and safety profiles and ran
Externí odkaz:
https://doaj.org/article/55e6c058767a4b0e8dd5c02846a9f74a
Autor:
Dae-Won Lee, Sae-Won Han, Yongjun Cha, Jeong Mo Bae, Hwang-Phill Kim, Jaemyun Lyu, Hyojun Han, Hyoki Kim, Hoon Jang, Duhee Bang, Jae-Kyung Won, Seung-Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Tae-You Kim
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Although the prognostic biomarkers associated with colorectal cancer (CRC) survival are well known, there are limited data on the association between the molecular characteristics and survival after recurrence (SAR). The purpose o
Externí odkaz:
https://doaj.org/article/6160588d637b430f94fc80d647175466
Publikováno v:
Molecular Oncology, Vol 12, Iss 7, Pp 993-1003 (2018)
Although regorafenib has demonstrated survival benefits in patients with metastatic colorectal and gastrointestinal stromal tumors, no proven biomarker has been identified for predicting sensitivity to regorafenib. Here, we investigated preclinical a
Externí odkaz:
https://doaj.org/article/be9cc0c3a27a4dd0bc7ca6a74ef39957
Autor:
June Young Chun, Se Ik Kim, Eun Young Park, Sang-Yoon Park, Su-Jin Koh, Yongjun Cha, Heon Jong Yoo, Jae Young Joung, Hong Man Yoon, Bang Wool Eom, Chul Min Park, Ji-Youn Han, Miso Kim, Dae-Won Lee, Jae-Weon Kim, Bhumsuk Keam, Maria Lee, Tae Min Kim, Young Ju Choi, Yoon Jung Chang, Myong Cheol Lim
Publikováno v:
Cancers, Vol 13, Iss 15, p 3883 (2021)
Considering the high morbidity and mortality of Coronavirus disease 2019 (COVID-19) in patients with malignancy, they are regarded as a priority for COVID-19 vaccination. However, general vaccine uptake rates among cancer patients are known to be low
Externí odkaz:
https://doaj.org/article/86fb6b1b8d454ccb9f2f2388d676d2b1
Autor:
Sae-Won Han, Yongjun Cha, Agnes Paquet, Weidong Huang, Jodi Weidler, Yolanda Lie, Thomas Sherwood, Michael Bates, Mojgan Haddad, In Hae Park, Do-Youn Oh, Keun Seok Lee, Seock-Ah Im, Yung-Jue Bang, Jungsil Ro, Tae-You Kim
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e39943 (2012)
BACKGROUND: Lapatinib plus capecitabine is an effective treatment option for trastuzumab-refractory HER2-positive metastatic breast cancer. We have investigated the correlation between quantitative measures of HER2, p95HER2, and HER3 and treatment ou
Externí odkaz:
https://doaj.org/article/526defc171974c2982015ad0bc9d86dd
Publikováno v:
Cancer Research & Treatment. Apr2023, Vol. 55 Issue 2, p367-384. 18p.
Autor:
Sheehyun Kim, Yongjun Cha, Yoojoo Lim, Hanseong Roh, Jun‐Kyu Kang, Kyung‐Hun Lee, Min Jung Kim, Ji Won Park, Seung‐Bum Ryoo, Hwang‐Phill Kim, Seung‐Yong Jeong, Kyu Joo Park, Sae‐Won Han, Tae‐You Kim
Publikováno v:
International Journal of Cancer.
Autor:
Shinkyo Yoon, Miso Kim, Yong Sang Hong, Han Sang Kim, Seung Tae Kim, Jihun Kim, Hongseok Yun, Changhoon Yoo, Hee Kyung Ahn, Hyo Song Kim, In Hee Lee, In-Ho Kim, Inkeun Park, Jae Ho Jeong, Jaekyung Cheon, Jin Won Kim, Jina Yun, Sun Min Lim, Yongjun Cha, Se Jin Jang, Dae Young Zang, Tae Won Kim, Jin Hyoung Kang, Jee Hyun Kim
Publikováno v:
Cancer Research and Treatment.
Publikováno v:
Oncology. 99:665-672
Background: Due to few efficacious options in later lines of therapy in metastatic colorectal cancer (mCRC), there has been considerable interest in the possibility of retreatment with previously administered agents. This study investigated the effic